Azathioprine

NIOSH table

Table 1 Antineoplastic — typically the focus of the strictest USP <800> handling controls.

AHFS classification

92:44 immunosuppressive agents; 92:20 immunomodulatory agents; 92:36 disease-modifying antirheumatic drugs

Carcinogenicity classification

IARC Group 1 carcinogen; NTP “known to be human carcinogen”

Screen the current package insert

This page reports this drug’s status on the NIOSH List of Hazardous Drugs in Healthcare Settings, 2024. It is not a hazard determination and not a handling instruction. Your facility makes its own Assessment of Risk under USP <800>. Package-insert content changes when the manufacturer revises the label — always screen the current insert before relying on it.